These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21427998)

  • 21. [Individual changes of gene expression in the interferon system in human blood cells due to amixin and cycloferon].
    Sokolova TM; Uryvaev LV; Tazulakhova EB; Ershov FI; Malyshenkova IK; Didkovskiĭ NA
    Vopr Virusol; 2005; 50(2):32-6. PubMed ID: 15881395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
    Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
    Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Up-to-date approach to treatment of inflammatory infections in the maxillofacial region].
    Romantsov MG; Kovalevskiĭ MA; Iaremenko AI; Grigorian SS; Kovalenko AL
    Antibiot Khimioter; 2009; 54(3-4):52-7. PubMed ID: 19711852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The cytokine status as a criterion for the efficacy of intranasal aerosol therapy with the use of a cycloferon solution in the patients presenting with allergic rhinosinusitis].
    Tataurshchikova NS; Sidorovich IG
    Vestn Otorinolaringol; 2012; (3):79-82. PubMed ID: 22951694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cycloferon in treating duodenal ulcers in rats].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kuznetsova NN; Anikin VB; arinenko RIu; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2001; 64(6):41-4. PubMed ID: 11871237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Using cycloferon in the complex treatment of herpetic infection in patients with atopic dermatitis].
    Barkhatova TS; Shul'diakov AA; Gavrilova IB; Sretenskaia DA
    Eksp Klin Farmakol; 2014; 77(3):37-9. PubMed ID: 24800525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cycloferon administration in chronic pyelonephritis: changes in interferon status].
    Kudriashova IP; Ospel'nikova TP; Ershov FI
    Ter Arkh; 2011; 83(6):33-5. PubMed ID: 21786573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of anogenital warts in an 18-month-old girl with 5% imiquimod cream.
    Sikanić Dugić N; Ljubojević Hadžavdić S; Pustišek N; Hiršl Hećej V
    Acta Dermatovenerol Croat; 2014; 22(1):40-3. PubMed ID: 24813840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients].
    Sukhanov DS; Okovityĭ SV; Demidik SN; Ivanov AK; Romantsov MG
    Eksp Klin Farmakol; 2012; 75(6):40-3. PubMed ID: 22891441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H
    Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cycloferon use in complex therapy of children with salmonellosis and yersiniosis infection].
    Kvetnaia AS; Bekhtereva MK; Zhelezova LI; Kalinogorskaia OS
    Antibiot Khimioter; 2012; 57(3-4):9-16. PubMed ID: 22993934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estimation of clinical-pathogenetic efficiency of reamberin and cycloferon application in patients with the severe form of acute tonsillitis].
    Frolov VM; Tereshkin VA; Sotskaia IaA; Peresadin NA; Kruglova OV
    Lik Sprava; 2013 Mar; (2):124-9. PubMed ID: 24605622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of cycloferon in a combined treatment of chlamydial conjunctivitis].
    Aznabaev MT; Latypova EA; Mal'khanov VB
    Vestn Oftalmol; 2003; 119(1):38-9. PubMed ID: 12608044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Type 1 and type 2 interferon inductor (cycloferon) in therapy of children with pyelonephritis associated with herpes viruses].
    Orekhova SB; Botvin'ev OK; Romantsov MG
    Antibiot Khimioter; 2009; 54(5-6):48-53. PubMed ID: 20052918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of laryngeal papillomatosis with interferon inducers].
    Karimova FS; Ivanchenko GF; Grigorian SS
    Vestn Otorinolaringol; 2000; (5):54-7. PubMed ID: 11051860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases].
    Lialikov SA; Romantsov MG; Bedin PG; Ermak SIu
    Antibiot Khimioter; 2012; 57(11-12):26-32. PubMed ID: 23700934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined therapy of patients with recurring anogenital herpes infection].
    Rakhmatulina MR
    Antibiot Khimioter; 2011; 56(11-12):25-9. PubMed ID: 22856154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of immunomodulators in the treatment of mandibular fractures in elderly patients with incomplete secondary adentia].
    Abramov AV; Parfenov SA; Belov VG; Parfenov IuA
    Eksp Klin Farmakol; 2014; 77(9):23-7. PubMed ID: 25365866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.